FSHD as a Disorder of Impaired RNA Biogenesis
FSHD 是一种 RNA 生物发生受损的疾病
基本信息
- 批准号:7290235
- 负责人:
- 金额:$ 11.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAlternative SplicingBiogenesisCandidate Disease GeneCell LineCell ProliferationCell modelCellsCharacteristicsChromatinChromatin StructureChromosomesComplexD4Z4DataDiseaseEpigenetic ProcessEventExonsFaceFacioscapulohumeralFacioscapulohumeral Muscular DystrophyGene Expression ProfileGenesGeneticGenomeHeterogeneous Nuclear RNAHumanIndiumInheritedIntervention StudiesKnowledgeLaboratoriesLentivirus VectorLocalizedMass Spectrum AnalysisMessenger RNAMitoticModelingMusMuscleMuscle CellsMuscular DystrophiesMyoblastsMyopathyMyotonic DystrophyNuclear StructureOculopharyngeal Muscular DystrophyOncogene DeregulationPathogenesisPathway interactionsPatientsPatternPharmacologic SubstancePhysiologicalProtein OverexpressionProteinsRNARNA InterferenceRNA SplicingRegulationRibonucleoproteinsRoleShoulderSiteSpliceosomesTranscriptTransfectionTransgenesTransgenic OrganismsTranslationsUpper armbaseexperienceindexingmRNA Precursormolecular pathologymouse modelsmall hairpin RNAtransgene expression
项目摘要
DESCRIPTION (provided by applicant):
Facioscapulohumeral muscular dystrophy (FSHD) is clinically characterized by progressive weakness of the facial, shoulder and upper arm muscles and is caused by contraction of the D4Z4 macrosatellite repeat in the subtelomere of chromosome 4q. In the US 15.000 people suffer from this disease for which there is no therapy. The pathogenic mechanism underlying FSHD is largely unknown but it is generally accepted that D4Z4 contraction causes a cascade of epigenetic events leading to transcriptional deregulation of one or more disease genes.
One of the candidate genes for FSHD is FRG1. It is considered a good candidate for FSHD because of its localization close to D4Z4, its high conservation, and because muscle-specific overexpression of FRG1 in mice causes muscular dystrophy. Observations from our and other laboratories consistently suggest a role for FRG1 in RNA biogenesis, but its exact function is unknown.
As FRG1 expression levels are high in mitotic active cells, FRG1 is upregulated in primary myoblast cultures of FSHD patients, high levels of FRG1 causes artificial nucleolar aggregates, and there is no faithful cell model for FSHD, we aim to study conditionally immortal myogenic cell lines with physiological relevant levels of FRG1-TAP overexpression, similar to what is observed in FSHD myoblasts. We propose to interrogate these cell models for the exact composition of the FRG1 ribonucleoprotein (RNP) complex at the protein and RNA level, during proliferation and in differentiation. We also propose to study the immediate effects of FSHD-like overexpression of FRG1 by quantitative (mRNA levels) and qualitative (exon use) transcriptome analysis, during proliferation and differentiation.
We expect this study to yield detailed information about the FRG1 RNP complex in a myogenic context, during proliferation and differentiation and to yield information on the immediate effects of subtle FRG1 overexpression. This knowledge will be essential to better understand the pathogenic mechanism underlying FSHD. Moreover, on the long term, we expect that uniform myogenic cell models with well-defined disease parameters for FSHD will be of importance for pharmaceutical intervention studies.
描述(由申请人提供):
面肩肱型肌营养不良症(FSHD)的临床特征是面部、肩部和上臂肌肉的进行性无力,并且是由染色体4 q的亚端粒中的D4 Z4大卫星重复的收缩引起的。在美国,有15000人患有这种疾病,没有治疗方法。FSHD的致病机制在很大程度上是未知的,但普遍认为D4 Z4收缩引起级联的表观遗传事件,导致一个或多个疾病基因的转录失调。
FSHD的候选基因之一是FRG 1。它被认为是FSHD的一个很好的候选者,因为它的定位接近D4 Z4,它的高度保守性,并且因为FRG 1在小鼠中的肌肉特异性过表达会导致肌营养不良。我们和其他实验室的观察一致表明FRG 1在RNA生物合成中的作用,但其确切功能尚不清楚。
由于FRG 1在有丝分裂活性细胞中表达水平高,FRG 1在FSHD患者的原代成肌细胞培养物中上调,高水平的FRG 1引起人工核仁聚集,并且FSHD没有忠实的细胞模型,我们的目的是研究具有生理相关水平的FRG 1-TAP过表达的条件永生肌细胞系,类似于在FSHD成肌细胞中观察到的。我们建议询问这些细胞模型的确切组成的FRG 1核糖核蛋白(RNP)复合物在蛋白质和RNA水平,在增殖和分化。我们还建议通过定量(mRNA水平)和定性(外显子使用)转录组分析,在增殖和分化过程中,研究FRG 1的FSHD样过表达的直接影响。
我们希望这项研究能够产生有关FRG 1 RNP复合物在肌源性背景下,在增殖和分化过程中的详细信息,并产生有关微妙的FRG 1过表达的直接影响的信息。这些知识对于更好地理解FSHD的致病机制至关重要。此外,从长远来看,我们预计具有明确定义的FSHD疾病参数的统一肌源性细胞模型将对药物干预研究具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SILVERE M VAN DER MAAREL其他文献
SILVERE M VAN DER MAAREL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SILVERE M VAN DER MAAREL', 18)}}的其他基金
Clonal isogenic and immortalized FSHD myoblasts with or without D4Z4 contraction
有或没有 D4Z4 收缩的克隆同基因永生化 FSHD 成肌细胞
- 批准号:
7978984 - 财政年份:2010
- 资助金额:
$ 11.61万 - 项目类别:
Identification of the gene defect underlying ICF2 syndrome
鉴定 ICF2 综合征背后的基因缺陷
- 批准号:
8080912 - 财政年份:2010
- 资助金额:
$ 11.61万 - 项目类别:
Clonal Isogenic and Immortalized FSHD Myoblasts with or without D4Z4 Contraction
有或没有 D4Z4 收缩的克隆同基因和永生化 FSHD 成肌细胞
- 批准号:
8138560 - 财政年份:2010
- 资助金额:
$ 11.61万 - 项目类别:
Identification of the gene defect underlying ICF2 syndrome
鉴定 ICF2 综合征背后的基因缺陷
- 批准号:
7953512 - 财政年份:2010
- 资助金额:
$ 11.61万 - 项目类别:
FSHD as a Disorder of Impaired RNA Biogenesis
FSHD 是一种 RNA 生物发生受损的疾病
- 批准号:
7493530 - 财政年份:2007
- 资助金额:
$ 11.61万 - 项目类别:
Llama-derived phage display antibody arrays for FSHD
用于 FSHD 的源自美洲驼的噬菌体展示抗体阵列
- 批准号:
6438421 - 财政年份:2001
- 资助金额:
$ 11.61万 - 项目类别:
Llama-derived phage display antibody arrays for FSHD
用于 FSHD 的源自美洲驼的噬菌体展示抗体阵列
- 批准号:
6665019 - 财政年份:2001
- 资助金额:
$ 11.61万 - 项目类别:
Llama-derived phage display antibody arrays for FSHD
用于 FSHD 的源自美洲驼的噬菌体展示抗体阵列
- 批准号:
6534543 - 财政年份:2001
- 资助金额:
$ 11.61万 - 项目类别:
Project 1: Pathways and mechanisms repressing D4Z4 repeats
项目 1:抑制 D4Z4 重复序列的途径和机制
- 批准号:
9767871 - 财政年份:
- 资助金额:
$ 11.61万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 11.61万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 11.61万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 11.61万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 11.61万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 11.61万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 11.61万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 11.61万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 11.61万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 11.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 11.61万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




